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Abstract

Parkinson’s disease is one of the most common degenerative neurological disorders and
is currently lacking a cure. While physicians have long debated over the best treatment
for Parkinson’s symptoms, treatments such as oral medication and deep brain stimulation
have not yet shown to be a permanent solution to the disease. Recently, exercise has
emerged as a contender in the fight against Parkinson’s and physicians and
physiotherapists have been investigating the benefits of prescribing exercise programs to
patients in an effort to slow progression of Parkinson’s symptoms. The following
presents an analysis of the effects of exercise on Parkinson’s symptoms and whether or
not the type of exercise prescribed is efficacious in the reduction in symptoms
experienced by patients. This analysis involves weighing the physical and psychological
benefits and risks of exercise intervention in individuals with Parkinson’s disease.
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The Physiology and Psychology of Exercise and Parkinson’s Disease
Medicine, like many other aspects of culture, is constantly changing. With these
advancements come a surge of new ideas as physicians attempt to determine the ideal
way to care for patients and treat illnesses. Although medication remains the gold
standard for the treatment of many chronic diseases, many physicians have begun to
encourage their patients to focus on diet and lifestyle changes as a form of preventive
medicine. This new lifestyle-centered care approach allows patients to take their health
into their own hands and experience tangible results as they witness first-hand how
changes in their diet and lifestyle will affect their health and quality of life. Although the
benefits of exercise are difficult to dispute, the idea of exercise as medicine has emerged
fairly recently, and with it comes the opportunity for extensive research on the benefits of
exercise as a potential treatment for many chronic diseases.
Overview of Parkinson’s Disease
Parkinson’s disease (PD) is a degenerative neurological disorder that affects the
body’s central nervous system (CNS), generally involving older individuals and, as of
yet, does not have a cure. Both men and women are at risk of developing PD, however,
the disease is twice as common among men (Bollinger, Cowan, & LaFontaine, 2012).
Recent research has shown that certain genes have been linked to PD and that first-degree
relatives of PD patients are at a higher risk of developing the disease themselves
(Bollinger et al., 2012). Symptoms of PD are caused by a deficiency in the dopaminegenerating cells of the brain. A chemical crucial to the initiation of movement, dopamine
is secreted from the substantia nigra of the midbrain and acts indirectly via a process
called the second messenger system, whereby dopamine binds to receptor proteins
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embedded in cell membranes, causing these proteins to in turn release chemicals that
affect intracellular functions (Marieb & Hoehn, 2013). In PD patients, the dopaminegenerating cells of the substantia nigra begin to deteriorate, causing their target cells to
become overactive (Marieb & Hoehn, 2013). With the death of the brain’s dopamine
cells resulting in a dopamine deficiency in the body, the movement-initiating parts of the
brain are not able to function at their former capacity. As dopamine levels continue to
diminish, Parkinson’s symptoms will worsen in a progressive manner (Heisters, 2011).
Many Parkinson’s patients are put on medications in order to minimize their
suffering and increase their ability to take care of themselves. However, these
medications will usually only mask the symptoms that patients are experiencing, and the
disease will continue to progress. Eventually, Parkinson’s patients will reach a point in
their disease progression where they are unable to care for themselves and become
dependent on either hospice care or a primary caregiver. Quality of life decreases until
life is no longer enjoyable for the patient due to the severity of symptoms and the
inability to perform even the simplest tasks of daily living. As with many diseases, early
intervention is encouraged with Parkinson’s patients. However, due to the relatively slow
progressive nature of PD, symptoms will not immediately appear to be severe and may be
dismissed as the effects of aging. The presence of only mild symptoms at disease onset
can lead to a delay in diagnosis and patients might not receive a correct diagnosis until
their symptoms have manifested significantly (Bollinger et al., 2012).
Motor Symptoms of Parkinson’s Disease
The most easily identifiable symptoms of Parkinson’s disease are the physical
symptoms, although they may originally be dismissed as the effects of aging until the
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disease has progressed further. Four major symptoms are indicative of Parkinson’s
disease: a resting postural tremor, bradykinesia (slowness of movement), stiffness or
rigidity of muscles, and decreased reflexes. Secondary symptoms include, but are not
limited to, dyskinesia (irregular movement patterns due to a loss of voluntary movement
control) and freezing (a sudden inability to generate movement) (Bollinger et al., 2012).
These symptoms generally affect aspects of movement such as gait and balance.
Parkinson’s patients generally experience difficulty walking, as well as difficulty
performing any quick or precise movements. Due to the progressive nature of PD,
physical symptoms will only get worse as the patient ages.
Non-motor Symptoms of Parkinson’s Disease
Perhaps more difficult to identify are the non-motor symptoms of PD, as some of
these symptoms are psychological by nature rather than physical. Symptoms include
apathy and depression, anxiety and stress, trouble sleeping, and impaired cognitive
function (Van der Kolk & King, 2013). Like the motor symptoms of PD, non-motor
symptoms are mild at disease onset with continued progression through the remaining
stages of life. A survey conducted in the United Kingdom in 2008 showed that the
severity of non-motor symptoms among PD patients increased with disease progression
(Breen & Drutyte, 2012). Although the majority of non-motor symptoms do not
contribute to movement deficiencies, symptoms such as depression and sleep disorders
can still affect patients physically. In fact, new advancements in a patient-centered
approach to the treatment and diagnosis of PD have shown that the non-motor symptoms
of the disease can affect patients just as severely, if not more so, than the motor
symptoms (Breen & Drutyte, 2012).
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Since Parkinson’s disease is an age-related disorder, symptoms of PD are often
accompanied by other age-related health issues such as high blood pressure, arthritis, and
cardiovascular disease (Bollinger et al., 2012). These age-related conditions are not
caused by PD, but the presence of these issues can make the already-uncomfortable life
of a Parkinson’s patient even worse.
Progression of Parkinson’s Symptoms
In order to ensure a universal assessment method for all PD patients, physicians
have adopted two separate scales in order to assess a patient’s symptoms. The Unified
Parkinson’s Disease Rating Scale (UPDRS) is used to rate the severity of a patient’s
symptoms, whereas the Hoehn and Yahr scale is used to rate the progression of a
patient’s symptoms. Although there had been few previous attempts to correlate UPDRS
values with Hoehn and Yahr values, a 2012 study revealed a significant correlation
between UPDRS and Hoehn and Yahr stage, going so far as to say that one could infer a
patient’s Hoehn and Yahr stage based on the individual’s UPDRS rating (Tsanas, Little,
McSharry, Scanlon, & Papapetropoulos, 2012). In other words, a physician should
generally be able to determine how far a patient’s disease has progressed depending on
the severity of the patient’s symptoms.
Hoehn & Yahr stage
0: No visible symptoms of Parkinson’s disease
1: Parkinson’s disease symptoms just on one side of the body
2: Parkinson’s disease symptoms on both sides of the body and
minimal difficulty moving
3: Parkinson’s disease symptoms on both sides of the body and
minimal difficulty walking
4: Parkinson’s disease symptoms on both sides of the body and
moderate difficulty walking
5: Parkinson’s disease symptoms on both sides of the body and
unable to walk

Figure 1. Hoehn and Yahr stages as a general
guideline for the progression of PD. (Tran, 2015)
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Treatment of Parkinson’s Disease
Prescription Medication
Recent studies have seen various opinions on the best method for treating
Parkinson’s disease. Treatment methods vary greatly, from oral medication to surgical
procedures and, recently, the introduction of the idea of exercise as a way of managing
the symptoms of PD. Levodopa has been one of the medications of choice for many
physicians attempting to slow the progression of PD in their patients. An intermediate in
the process of dopamine formation, orally ingested levodopa makes its way to the brain
where it assists in the production of dopamine in an effort to correct dopamine
deficiencies caused by PD. In some cases, physicians may prescribe a pump instead of
oral medication in order to better control a patient’s doses and to adjust a continuous flow
of medication as symptoms fluctuate throughout the day. However, although levodopa
functions incredibly well for most patients at the beginning of prescription, it has been
shown to cause motor complications later in life. Additionally, treatment with levodopa
has been shown to cause adverse side effects, including nausea, in some patients, which
physicians have attempted to counter by prescribing a combination of levodopa and
carbidopa, a drug which has come to be referred to as the gold standard of PD treatment
(Rascol, 2013). Unfortunately, while levodopa has been shown to slow progression of PD
in the short term, it appears to function only so long as patients continue to take the
medication and long term effects of levodopa on PD remain uncertain (LeWitt, 2008).
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Deep Brain Stimulation in Addition to or as an Alternative to Prescription
Medication
Researchers are still in search of a PD treatment that continues to work long term.
Recently, Deep Brain Stimulation (DBS) has emerged as a contender to oral medication.
The surgical process involves the implantation of a small electrode in the brain that can
then be turned on or off depending on the patient’s needs. The device, which essentially
functions as a pacemaker in the brain, is responsible for decreasing Parkinson’s
symptoms via stimulation, providing patients with an alternative to oral medication.
While some physicians still prescribe oral medication to DBS patients, the dosages are
significantly reduced. The DBS treatment has been shown to improve motor function,
speech, and occasionally mood and perceived quality of life of the patient (Benabid,
2003). However, as with any surgery, there are multiple risks associated with the DBS
process and in the past it has been seen as a last resort treatment. Additionally, only a
small percentage of PD patients qualify for DBS because of the high risks associated with
the procedure. According to Limousin and Martinez-Torres (2008), patients who
experience mental disorders such as dementia or psychosis run the risk of their conditions
worsening following the DBS procedure. This accelerated deterioration is likely due to a
combination of the stimulation and a sudden reduction in oral medication doses
(Limousin & Martinez-Torres, 2008). Furthermore, certain patients, particularly those
who exhibit freezing and balance problems, reported inconsistent results in their
symptoms after receiving the surgery (Limousin & Martinez-Torres, 2008). Generally,
the DBS procedure is not performed until 11-13 years after the onset and diagnosis of
PD, although recently physicians have discovered that patients could potentially benefit
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from having the surgery earlier (Godden, 2014). The fact remains, however, that neither
the levodopa-carbidopa combination nor DBS is a permanent solution to Parkinson’s
disease. While various treatments are available, the disease is still lacking a cure, and
while researchers have by no means stopped searching for a cure, much of the focus in
PD treatment has shifted to attempts to alleviate symptoms, slow disease progression, and
help maintain patient quality of life for as long as possible.
Exercise Therapy as a Treatment for Parkinson’s Disease
In light of the ever-increasing popularity of diet and lifestyle changes as a
treatment for a variety of problems, exercise has emerged as a potential solution to the
decreased motor function and quality of life associated with aging and, more specifically,
Parkinson’s disease. Opinions differ on how effective this kind of treatment is, as the
effectiveness of treatment depends largely on the specific patients treated, as well as the
type, intensity, and duration of exercise prescribed. A study done by Dibble, Hale,
Marcus, Gerber, and LaStayo (2009) showed a decrease in bradykinesia (slowness of
movement) and an improved quality of life in patients ages 40-85 suffering from mild to
moderate PD (Hoehn & Yahr stages 1-3) who participated in a high intensity resistance
training program. Previous exercise interventions among Parkinson’s patients have
typically not highlighted resistance training as an important part of the exercise program.
However, resistance training results in significant increases in muscular strength and
endurance, and increases in muscular strength and endurance are especially important for
those suffering from movement disorders (Pescatello, 2014). The key to using exercise
therapy as a treatment for PD, however, is to use a well-rounded exercise program that
focuses on maintaining range of motion, strength, balance, and movement speed, and this
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cannot be accomplished solely through resistance training. Generally, the best exercises
to help slow disease progression in PD patients are those that emphasize balance,
movement initiation, and movement control (Pescatello, 2014). The LSVT (Lee
Silverman Voice Treatment) programs for PD patients have been designed for this
purpose. Originally the LSVT Loud program was developed as a speech therapy program
for PD patients, with the LSVT Big program added in an effort to treat movement
deficiencies in addition to speech deficiencies. The goal of the LSVT Big program is to
emphasize amplitude of movement instead of speed. Additionally, patients are coached
on movement precision and accuracy (Fox, Ebersbach, Ramig, & Sapir, 2012).
Conversely, a training program that focuses solely on aerobic exercise and cardiovascular
endurance would not greatly benefit PD patients. Although individuals with Parkinson’s
can improve their cardiorespiratory endurance just like anyone else (Bergen et al., 2002),
this kind of exercise does not do much to improve balance and movement initiation.
Cardiorespiratory endurance is still an extremely important component of physical
fitness, but the prescription of aerobic exercise does not target the movement deficiencies
caused by Parkinson’s disease.
The American College of Sports Medicine (ACSM) recommends an exercise
prescription for PD patients that places focus on improving gait, transfers, balance, joint
mobility, and muscle power (Pescatello, 2014). The ideal exercise program should
address all components of physical fitness (muscular strength, muscular endurance,
cardiorespiratory endurance, and flexibility) in addition to addressing gross functional
movement and more precise fine motor skills. Naturally, a PD patient’s exercise program
needs to be under constant revision, as a combination of disease progression and the
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effects of aging may prevent patients from performing exercises they were once capable
of. While it is certainly possible for PD patients to show improvement in the various
areas of physical fitness, a more realistic goal is maintenance of current physical fitness
levels for as long as possible, and focus on delaying the onset of symptoms. Due to the
progressive nature of PD, the ACSM emphasizes the importance of early intervention
when prescribing an exercise program to PD patients, as a patient’s ability to participate
in physical activity will decrease the longer the disease is allowed to progress.
Effects of Various Exercise Interventions on Parkinson’s Disease
Parkinson’s Disease and Aerobic Exercise
A study published in 2002 analyzed the effects of a sixteen week aerobic exercise
intervention on both aerobic capacity and movement initiation in PD patients (Bergen et
al., 2002.) According to the researchers:
[A]erobic exercise has been shown to play a significant role in the prevention and
reversibility of chronic diseases such as coronary heart disease, diabetes, and
osteoporosis; however, very little conclusive evidence is available concerning the
effects of aerobic exercise on PD. (Bergen et al., 2002, p. 161)
For the purposes of the study, aerobic capacity was defined as an individual’s peak VO2,
and movement initiation (MI) was defined as the amount of time required for elbow
flexion and extension. Eight participants aged 47 to 74, all of whom were in Hoehn and
Yahr stage 2, were assigned to either a control group or an intervention group. After
undergoing a pre-test for peak VO2 and MI times, the control group was instructed to
continue on with their regular exercise routine, while the intervention group was
prescribed a sixteen week aerobic exercise intervention that consisted of stretching
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exercises and a combination of cycling and treadmill walking with speed and resistance
adjusted to keep participants in their target heart rate (THR) zone at all times. Following
the sixteen week period, all participants completed a post-test to assess changes in their
MI and peak VO2. Participants in the intervention group showed remarkable
improvement, improving their peak VO2 scores by an average of 5.0 mL/kg/min in
addition to improving their MI time by approximately 120 ms. Additionally, following
the sixteen week intervention, mean MI times for the intervention group were closer to
those of healthy non-PD individuals than to members of the PD control group.
Results of this study are important, as they show that PD patients have the ability
to improve their movement initiation with exercise, showing that PD symptoms, despite
their progressive nature, are at least somewhat reversible. Additionally, this study shows
that MI can be improved solely through aerobic exercise in conjunction with stretching,
with no additional resistance training or emphasis on gross motor skills. However,
although improvement in MI was shown following the sixteen week intervention, there is
no indication of whether or not these gains were maintained when exercise ceased, or
only lasted so long as the individual continued with the aerobic exercise program.
Improvement in peak VO2 among participants in the intervention group, although
significant, is to be expected, and this trend is not limited to PD patients as aerobic
exercise has been shown to increase cardiorespiratory fitness in healthy as well as
diseased individuals. An increase in peak VO2, although beneficial to the subject, likely
has no effect on the motor symptoms of PD. It is more likely that the significant increases
in VO2 are present to indicate that the aerobic intervention worked for its intended
purpose (increasing the cardiorespiratory endurance of the patients who participated in
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the program). Furthermore, all participants studied were in Hoehn and Yahr stage 2,
indicating that they were experiencing symptoms but did not yet have any difficulty
walking. While there is no doubt that the aerobic exercise intervention was beneficial for
these patients, aerobic exercise may not be the ideal intervention for individuals whose
disease has progressed further (Hoehn and Yahr stages 3-5).
An additional criticism of this study is the fact that so few participants were used;
only four in the control group and four in the intervention group. This is likely due to the
difficulty in finding a large enough sample of PD patients who are at the same stage in
their disease progression and are capable of completing the required sixteen weeks of
exercise without having to drop out of the study. However, despite the fact that patients
in the intervention group showed a significant increase in VO2max and movement
initiation time, one must wonder how comparable the results can possibly be to the PD
population as a whole if only four participants were used. It is possible that these four
patients were special cases and that an aerobic exercise intervention would not actually
improve MI times among the majority of Parkinson’s patients. Although the results found
were significant, a larger sample size would be needed before the results of this study
could be seen as meaningful.
A different study conducted in 2006 used 22 PD patients in Hoehn and Yahr
stages 2-3 and focused on an exercise intervention that combined aerobic training with
Qigong, a Chinese physiotherapy method that focuses on stretching and breathing
exercises and has been shown to improve self-reported quality of life in individuals with
chronic conditions (Burini et al., 2006). This study, like the study done by Bergen et al.,
showed that Parkinson’s patients can achieve cardiorespiratory gains through aerobic
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exercise just like healthy individuals. However, the Burini et al. study was unable to find
any significant impact of aerobic exercise on PD symptoms, nor was there a significant
difference in perceived quality of life in patients following the intervention.
Parkinson’s Disease and Resistance Training
In 2009, Dibble et al. published one of the first studies to look at the impact of
high intensity resistance training on Parkinson’s symptoms. Twenty participants ages 4085 in Hoehn and Yahr stages 1-3 were recruited to take part in a twelve week program
and were randomly assigned to either a control group or an intervention group. In this
case, both groups followed an exercise program and the variable was the addition of high
intensity resistance training for the participants in the intervention group. Participants
were pre-tested for force generation (via isometric contraction of the quadriceps muscle),
bradykinesia during gait (via a 10m walk and timed up and go tests) and were asked to
indicate their perceived quality of life through the Parkinson’s Disease Questionnaire
(Dibble et al., 2009). Following the twelve week intervention, participants were posttested on the same criteria.
Participants in both the control and experimental groups showed strength gains
following the intervention. Most interesting, however, were the changes shown in
bradykinesia. While the control group showed a decrease in gait speed over the twelve
week period, the intervention group that completed high intensity resistance training in
addition to the standard exercise protocol showed a 12% increase in walking speed on the
timed 10m walk. Additionally, participants in the intervention group achieved faster
times on their timed up and go post-test, while participants in the control group showed
virtually no change in times from pre-test to post-test.
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Although ASCM exercise prescription guidelines generally do not recommend
high intensity resistance training with frail, elderly, or movement-impaired individuals,
this study provides interesting insight into the ways that a resistance training program
could potentially be beneficial for certain Parkinson’s patients. However, the benefits of
such a program do not come without risks, and it is imperative that patients engage in
resistance training in a safe and controlled environment in addition to obtaining clearance
from a physician prior to beginning exercise. Furthermore, such a program, although
beneficial for patients in early stages of PD, would not be recommended for patients with
severe movement deficiencies such as those in Hoehn and Yahr stages 4 and 5.
Parkinson’s Disease and Assisted Cycling
In keeping with the idea of using intensity as a variable in an exercise program for
PD patients, a study published in 2012 looked at altering an individual’s cycling cadence
on a stationary bicycle, enabling patients to achieve a faster pedaling rate than they would
normally be capable of on their own (Ridgel, Peacok, Fickes, & Kim, 2012). A previous
study done by Ridgel, Vitek, and Alberts (2008) looked at the impact of forced versus
voluntary exercise by assigning ten patients to one of two groups: a control group where
they were instructed to cycle on their own, or an experimental group where patients were
placed on a tandem bike with a trainer and were forced to pedal at the same speed as the
trainer (a cadence faster than their own voluntary speed) through a system that linked the
pedals of the participant to the pedals of the trainer. The results of this study showed a
35% motor function increase in patients placed in the forced exercise group, compared to
no increase in motor function in the group that was allowed to determine their own
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cycling cadence. Patients from both groups showed an improvement in their
cardiorespiratory endurance.
The 2012 study utilized an active assisted cycling system that functioned similar
to the tandem bicycle, but with the absence of a trainer, in an effort to identify whether or
not high intensity assisted cycling could be used as an exercise intervention for PD
patients in the home and to determine the possibility of active assisted cycling as an
alternative to the tandem cycling used in the 2008 study. The modified assisted cycling
system consisted of a stationary bicycle, which was computerized in order to allow
patients to select a set cadence. Patients were instructed to attempt to pedal faster than the
set cadence, but in the event that they were unable to do so, the computerized system took
over and began to move their legs for them, ensuring that all patients maintained a speed
of at least 75 revolutions per minute (rpm) throughout their workout. Patients were tested
in both ON and OFF medication states in order to determine whether or not a single
session of active assisted cycling would have an effect on bradykinesia and resting
postural tremor regardless of whether or not the individual was relying on medication.
Ten participants in the study aged 54-75 (Hoehn & Yahr stages 1-3) were tested for
bradykinesia and resting postural tremor both before and after completing a single 30
minute cycling session.
The post-test revealed an immediate change in the bradykinesia and resting
postural tremor of patients following their cycling session. Furthermore, despite the fact
that the cycling intervention focused solely on the legs, patients showed improvement in
bradykinesia and resting postural tremor of the hands, indicating that the cycling
intervention had an impact on the entire central nervous system instead of being strictly
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limited to the parts of the body that were stressed in the exercise intervention. These
findings coincide with the findings from the Bergen et al. (2002) study, where aerobic
training improved movement initiation time despite the fact that movement initiation was
never trained directly in the exercise intervention. Additionally, Ridgel et al. (2012)
found that the cycling session lessened disease symptoms by affecting the same areas of
the brain that are usually affected by Parkinson’s medication. The fact that acute bouts of
active assisted cycling affect the body in similar ways as medication is groundbreaking,
as it presents exercise as a potential alternative for medication in the early stages of PD.
In addition, participants showed improvement after only a single exposure to the exercise
intervention, suggesting that a long and complicated exercise regimen is not required in
order for PD patients to begin to experience alleviation of symptoms.
Taking a Biopsychosocial Approach to Parkinson’s Disease
While treating the motor symptoms of PD deals purely with the body’s
physiology, non-motor symptoms present an additional host of complications. Not only
do patients experience dizziness, incontinence, difficulty speaking and swallowing, and
trouble with sleeping, those who suffer from PD can also develop severe anxiety and
depression and may suffer from pain and hallucinations. Additionally, approximately one
third of PD patients will develop dementia, usually within 12 years of being diagnosed
with Parkinson’s (Heisters, 2011). Although it can be easy to overlook the non-motor
symptoms of PD in favor of treating the motor symptoms, new developments in medicine
have begun to encourage physicians to focus on the biopsychosocial approach to treating
patients; an approach born out of the criticism that physicians place too heavy of a focus
on the biological components of a patient’s disease, sometimes to the point of neglecting
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the patient’s psychological and social well-being. The biopsychosocial model of health
seeks to correct this issue in health care by mandating that physicians take a more open
and well-rounded approach to illnesses, focusing on the way that the illness affects the
patient as a person and prioritizing the patient’s overall quality of life over the importance
of the treatment of individual symptoms (Zittel, Lawrence, & Wodarski, 2002). The idea
behind taking a biopsychosocial approach to care is that patients will be far more open to
various treatment options if they already feel safe and content about their overall quality
of life. In contrast, medications will not appear to be as effective in the cases of patients
whose disease causes them to experience severe bouts of anxiety and depression, as
physicians design the majority of PD treatments with a focus on alleviating motor
symptoms and generally do not have the psychological symptoms of the disease in mind.
Exercise and Depression
Major depressive disorder (MDD) affects an estimated 16% of Americans (Aan
het Rot, Collins, & Fitterling, 2009), and, along with anxiety, is one of the major
psychological symptoms that affects individuals diagnosed with PD (Breen & Drutyte,
2012). In fact, a Finnish study published in 2000 showed that the individuals who scored
the highest for depression were those who suffered from a chronic disease or injury
(Hassmén, Koivula, & Uutela, 2000). While these findings are not unexpected, as it
makes sense that those who suffer from chronic illness will experience the feelings of
unease and helplessness that often lead to depression. This adds additional complexity to
the treatment of chronic diseases such as PD, as depression is a disease in itself, albeit a
mental disease instead of a physical one, and therefore must be treated as such.
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The Hassmén et al. (2000) study attempted to determine the effects of exercise on
depression by surveying participants on their exercise habits and then scoring them on the
Beck Depression Inventory (BDI), a 21 question assessment that ranks individuals on
various components of MDD before giving them a score on the depression scale.
Analysis of the survey results showed that those who indicated that they exercised
infrequently or not at all scored higher on the depression scale than those who indicated
exercising two to three times a week. Interestingly, results also showed that individuals
who reported exercising most often (almost every day of the week) also scored higher on
the depression scale than the individuals who exercised two to three times per week.
These findings indicate that a moderate exercise program of two to four days per week
would likely be ideal in order to minimize the chances of a high score on the depression
scale. Additionally, these findings coincide with findings about the neurobiology of
exercise, including the phenomenon generally referred to as runner’s high; the state of
elation and decreased sensitivity to pain that is often experienced by athletes following a
long run. This is due to the release of endorphins; a type of opioid that has been shown to
regulate mood and induce the euphoria seen in many runners. However, it should be
noted that the runner’s high phenomenon does not seem to affect all runners, nor does it
appear to affect runners with much consistency (Aan het Rot et al., 2009). Another
hypothesis focuses on the levels of serotonin and norepinephrine, both neurotransmitters
that have been linked to depressive effects when deficient in the body. Studies have
shown that exercise increases the levels of tryptophan, the amino acid from which
serotonin is derived, in addition to decreasing levels of various other amino acids that
compete with tryptophan in the brain. This increase in serotonin is similar to the way that
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many antidepressant medications function (Aan het Rot et al., 2009), presenting a link
between the psychological benefits of exercise and the body’s response to antidepressant
medication and showing that exercise could potentially be used as an antidepressant.
The path towards alleviating symptoms of depression is, however, infinitely more
complicated than simply instructing patients to exercise. According to the Diagnostic and
Statistical Manual of Mental Disorders (DSM-5), symptoms of MDD include “the
presence of sad, empty, or irritable mood, accompanied by somatic and cognitive changes
that significantly affect the individual’s capacity to function” (American Psychiatric
Association, 2013, p.155). Along with these symptoms comes a severe lack of
motivation; those who suffer from depression lack the energy to do the things they enjoy
and the excitement that once accompanied their favorite activities. In addition, depression
affects the physiology of patients so that they feel too tired, too sick, or simply less alive
(Aan het Rot et al., 2009). One of the major reasons that individuals choose not to
exercise is lack of motivation, whether intrinsic or extrinsic, and individuals who suffer
from depression and by proxy a severe lack of motivation, are therefore even less likely
to begin an exercise program in comparison to the average individual. Additionally,
today’s society is, unfortunately, one of instant gratification, meaning that individuals are
unlikely to engage in a behavior that does not provide immediate benefits for them.
Although acute bouts of exercise have been shown to decrease depressive symptoms in
individuals (North, McCullagh, & Tran, 1990), the long term gains of chronic exercise
will always be greater and more noticeable than the gains from a single bout of acute
exercise. Unfortunately, patients who begin an exercise program and do not see
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immediate gains may write off the benefits of exercise before they have a chance to
notice any physical or psychological improvements.
An additional complication, in the case of PD patients, is that they may have the
desire to exercise but not the ability. While individuals still in the early stages of the
disease are capable of walking, running, cycling, and even resistance training, patients
who have progressed to Hoehn and Yahr stages 4 and 5 may be physically incapable of
participating in exercise for prolonged periods of time. Although exercise intervention in
the early stages of PD could potentially serve to delay the onset of depressive symptoms,
the knowledge that exercise affects the brain in a manner similar to that of medication
shows that exercise interventions are by no means a cure, simply another way of
alleviating symptoms.
Social Support
The social component of chronic disease is often overlooked, although it has an
arguably greater impact on a patient’s life than anything else. Those who suffer from
chronic diseases are often bed-ridden, in and out of the hospital, or in hospice care,
severely impacting their ability for social interaction. However, like all people, these
patients still crave relationships and human interaction. The unfortunate truth is that
many PD patients seem to lack the level of social support that they need, and instead live
their lives in various stages of isolation. A patient’s lack of social support could stem
from a variety of reasons. Since PD primarily affects the elderly, especially in its late
stages, some patients lack a social support system due to already having lost many of
their loved ones. Alternatively, friends and family members of those who suffer from PD
may become intimidated by the amount of time and effort involved in caring for someone
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with a chronic disease and come to view the individual as a burden, electing to place the
patient in a hospice or some other form of long-term care. Unfortunately, situations in
which PD patients are removed from their support network are far from ideal, and could
potentially cause the individual’s anxiety and depression to worsen (Adams, Sanders, &
Auth, 2004).
With the rise in popularity of the biopsychosocial model of medicine has come an
increase in the integration of social care into the treatment of PD. Hospitals, hospices,
retirement homes, and physiotherapy clinics offer group exercise classes such as cycling,
chair exercises, and dance classes. Additionally, organizations such as the Parkinson’s
Society Canada and the American Parkinson’s Disease Association have been making an
effort to provide patients and their caregivers with education about their disease, their
treatment options, and ways to get involved with groups that offer social support. For PD
patients, these groups are the best of both worlds, as they provide individuals with the
opportunity to simultaneously exercise and socialize; opportunities that are more difficult
to come by when living with a chronic disease. Additionally, these groups can serve to
provide accountability for individuals who may not be motivated to exercise or socialize
if they did not have others counting on them. Taking an activity like exercise that may
seem daunting, especially to patients who may be suffering from depression and lack
energy and motivation, and turning it into a social activity can make it seem like less of a
chore and more something that the patient favorably anticipates. The focus of the
biopsychosocial model of care is on the patient as a whole, which means making every
effort to maximize the patient’s quality of life throughout their treatment process.
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Parkinson’s Treatment and Christianity
Perhaps the biggest controversy in the Christian medical world is that of quality
of life versus quantity of life. In other words, is it better to prolong a patient’s life through
whatever means necessary, occasionally with disregard to the patient’s wishes? Or is it
better to make the patient feel comfortable and safe in the midst of their disease, even if it
means foregoing a treatment that could potentially save an individual’s life? Christians in
the medical field are often faced with this dilemma when asked to make a choice that
could mean the difference between a patient’s life and death. In a way, the Christian
worldview aligns with the biopsychosocial model of medicine, emphasizing treatment of
the patient as an individual instead of treating them as if they are their disease. It is
important to remember that God is not as much concerned with the amount of time
people spend on this earth as he concerned with what individuals do with the life that He
has given to them, and Christian physicians should keep this in mind when treating
patients who suffer from chronic diseases such as PD.
Exercise intervention in patients suffering from Parkinson’s disease has the
potential to delay the progression of a patient’s symptoms and improve motor function in
patients with severe movement deficiency, enabling individuals to more easily
accomplish activities of daily living. In addition to its physical benefits, exercise has been
shown to have a positive effect on individuals suffering from anxiety and depression, and
an increase on an individual’s perceived quality of life. Furthermore, exercise can be used
as a means of socialization, providing patients with much needed support and interaction.
In light of the innumerable benefits of participation in physical activity by patients living
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with chronic disease, it can be concluded that an exercise intervention program is a
valuable addition to the treatment of patients suffering from Parkinson’s disease.
The Future of Parkinson’s Disease
Despite the fact that medicine has progressed by leaps and bounds and is far more
advanced than it was only a decade ago, many chronic progressive diseases like
Parkinson’s are still lacking a cure, and while time and energy should certainly be spent
searching for a cure, it is of equal importance to provide treatment for those who are
currently suffering from PD. Additionally, early intervention is of utmost importance
when dealing with a progressive disease. Although it has been shown that it is possible
for PD patients to gain back some of the motor function they have lost with the help of
exercise, motor function will become more and more difficult to regain the further the
disease is allowed to progress without intervention.
Since PD is such a highly individual disease, one patient’s symptoms will not
necessarily progress in the same manner as another patient’s, nor will the treatment used
for a certain patient necessarily be the best option for another. Because of this, physicians
need to take care to know their patient in order to prescribe the best treatment in order to
maximize quality of life.
Although oral medication and DBS certainly function to alleviate PD symptoms
and improve the patient’s quality of life, there is an argument to be made for exercise
intervention as an initial treatment before resorting to prescription medication and
surgeries. Since exercise can help PD patients to regain motor function, it stands to
reason that exercise could also act as a preventive measure against the loss of motor
function. The longer that patients can delay the onset of disease symptoms by exercising,
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the longer they can put off becoming dependent on medication or DBS to alleviate their
symptoms.
The unfortunate truth of PD is that the symptoms are inevitable, and they will
invariably get worse as the disease is allowed to progress over time. While there is
potential for symptom reversal, the disease is, by nature, progressive, and focus should
therefore be placed on the prevention of symptoms rather than on the potential to reverse
them. While medication and DBS alleviate symptoms and increase the ease with which a
patient can perform activities of daily living, they do not serve to prevent or delay
symptoms, only to make it easier for patients to live with the disease. Exercise, on the
other hand, serves to help patients to maintain their fitness levels and motor function for
as long as possible, in addition to decreasing the risk of age-related symptoms that may
accompany PD.
Further Research
Although exercise intervention has been shown to delay the progression of
symptoms or even reverse symptoms, such as in the case of improvements in the MI
times of patients involved in the Bergen et al. (2002) study, there is little indication of
whether or not these gains will last long term, especially if patients cease to exercise.
Additionally, there seems to be minimal research comparing the symptoms of sedentary
PD patients who were active before their diagnosis to the symptoms of PD patients who
have been sedentary their entire life to determine whether or not an active lifestyle prediagnosis will contribute to less severe symptoms as an individual’s disease progresses.
Additional areas that would benefit from further research include whether or not it is
possible for exercise intervention to cause a reversal in Hoehn and Yahr stages or
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UPDRS rating, as well as determining how long the effects of exercise on PD symptoms
will last if the patient ceases to participate in physical activity.
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